FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087897706> ?p ?o ?g. }

• W2087897706 endingPage "1772" @default.
• W2087897706 startingPage "1772" @default.
• W2087897706 abstract "Fecal microbiota transplantation (FMT) has been shown to be effective in treating relapsing or refractory Clostridium difficile infection, but practical barriers and safety concerns have prevented its widespread use.To evaluate the safety and rate of resolution of diarrhea following administration of frozen FMT capsules from prescreened unrelated donors to patients with recurrent C. difficile infection.Open-label, single-group, preliminary feasibility study conducted from August 2013 through June 2014 at Massachusetts General Hospital, Boston. Twenty patients (median age, 64.5 years; range, 11-89 years) with at least 3 episodes of mild to moderate C. difficile infection and failure of a 6- to 8-week taper with vancomycin or at least 2 episodes of severe C. difficile infection requiring hospitalization were enrolled.Healthy volunteers were screened as potential donors and FMT capsules were generated and stored at -80°C (-112°F). Patients received 15 capsules on 2 consecutive days and were followed up for symptom resolution and adverse events for up to 6 months.The primary end points were safety, assessed by adverse events of grade 2 or above, and clinical resolution of diarrhea with no relapse at 8 weeks. Secondary end points included improvement in subjective well-being per standardized questionnaires and daily number of bowel movements.No serious adverse events attributed to FMT were observed. Resolution of diarrhea was achieved in 14 patients (70%; 95% CI, 47%-85%) after a single capsule-based FMT. All 6 nonresponders were re-treated; 4 had resolution of diarrhea, resulting in an overall 90% (95% CI, 68%-98%) rate of clinical resolution of diarrhea (18/20). Daily number of bowel movements decreased from a median of 5 (interquartile range [IQR], 3-6) the day prior to administration to 2 (IQR, 1-3) at day 3 (P = .001) and 1 (IQR, 1-2) at 8 weeks (P < .001). Self-ranked health scores improved significantly on a scale of 1 to 10 from a median of 5 (IQR, 5-7) for overall health and 4.5 (IQR, 3-7) for gastrointestinal-specific health on the day prior to FMT to 8 (IQR, 7-9) after FMT administration for both overall and gastrointestinal health (P = .001). Patients needing a second treatment to obtain resolution of diarrhea had lower pretreatment health scores (median, 6.5 [IQR, 5-7.3] vs 5 [IQR, 2.8-5]; P = .02).This preliminary study among patients with relapsing C. difficile infection provides data on adverse events and rates of resolution of diarrhea following administration of FMT using frozen encapsulated inoculum from unrelated donors. Larger studies are needed to confirm these results and to evaluate long-term safety and effectiveness.clinicaltrials.gov Identifier: NCT01914731." @default.
• W2087897706 created "2016-06-24" @default.
• W2087897706 creator A5006342786 @default.
• W2087897706 creator A5011101511 @default.
• W2087897706 creator A5014080946 @default.
• W2087897706 creator A5032939282 @default.
• W2087897706 creator A5073011180 @default.
• W2087897706 creator A5085014241 @default.
• W2087897706 date "2014-11-05" @default.
• W2087897706 modified "2023-10-05" @default.
• W2087897706 title "Oral, Capsulized, Frozen Fecal Microbiota Transplantation for Relapsing<i>Clostridium difficile</i>Infection" @default.
• W2087897706 cites W1968626722 @default.
• W2087897706 cites W1968839414 @default.
• W2087897706 cites W1968953113 @default.
• W2087897706 cites W1974373854 @default.
• W2087897706 cites W1998272935 @default.
• W2087897706 cites W2032356948 @default.
• W2087897706 cites W2033589094 @default.
• W2087897706 cites W2033649854 @default.
• W2087897706 cites W2063317482 @default.
• W2087897706 cites W2065777365 @default.
• W2087897706 cites W2105363440 @default.
• W2087897706 cites W2107440389 @default.
• W2087897706 cites W2113556993 @default.
• W2087897706 cites W2134900799 @default.
• W2087897706 cites W2146116383 @default.
• W2087897706 cites W2148171446 @default.
• W2087897706 cites W2149642295 @default.
• W2087897706 cites W2150595184 @default.
• W2087897706 cites W2153534612 @default.
• W2087897706 cites W2154585806 @default.
• W2087897706 cites W2158871837 @default.
• W2087897706 cites W2166660180 @default.
• W2087897706 cites W2168453790 @default.
• W2087897706 cites W2607397409 @default.
• W2087897706 doi "https://doi.org/10.1001/jama.2014.13875" @default.
• W2087897706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25322359" @default.
• W2087897706 hasPublicationYear "2014" @default.
• W2087897706 type Work @default.
• W2087897706 sameAs 2087897706 @default.
• W2087897706 citedByCount "526" @default.
• W2087897706 countsByYear W20878977062014 @default.
• W2087897706 countsByYear W20878977062015 @default.
• W2087897706 countsByYear W20878977062016 @default.
• W2087897706 countsByYear W20878977062017 @default.
• W2087897706 countsByYear W20878977062018 @default.
• W2087897706 countsByYear W20878977062019 @default.
• W2087897706 countsByYear W20878977062020 @default.
• W2087897706 countsByYear W20878977062021 @default.
• W2087897706 countsByYear W20878977062022 @default.
• W2087897706 countsByYear W20878977062023 @default.
• W2087897706 crossrefType "journal-article" @default.
• W2087897706 hasAuthorship W2087897706A5006342786 @default.
• W2087897706 hasAuthorship W2087897706A5011101511 @default.
• W2087897706 hasAuthorship W2087897706A5014080946 @default.
• W2087897706 hasAuthorship W2087897706A5032939282 @default.
• W2087897706 hasAuthorship W2087897706A5073011180 @default.
• W2087897706 hasAuthorship W2087897706A5085014241 @default.
• W2087897706 hasBestOaLocation W20878977061 @default.
• W2087897706 hasConcept C126322002 @default.
• W2087897706 hasConcept C137923570 @default.
• W2087897706 hasConcept C141071460 @default.
• W2087897706 hasConcept C151730666 @default.
• W2087897706 hasConcept C197934379 @default.
• W2087897706 hasConcept C2778980435 @default.
• W2087897706 hasConcept C2779489039 @default.
• W2087897706 hasConcept C2779802037 @default.
• W2087897706 hasConcept C2911091166 @default.
• W2087897706 hasConcept C2994496256 @default.
• W2087897706 hasConcept C501593827 @default.
• W2087897706 hasConcept C523546767 @default.
• W2087897706 hasConcept C54355233 @default.
• W2087897706 hasConcept C61716771 @default.
• W2087897706 hasConcept C71924100 @default.
• W2087897706 hasConcept C86803240 @default.
• W2087897706 hasConcept C89423630 @default.
• W2087897706 hasConcept C90924648 @default.
• W2087897706 hasConceptScore W2087897706C126322002 @default.
• W2087897706 hasConceptScore W2087897706C137923570 @default.
• W2087897706 hasConceptScore W2087897706C141071460 @default.
• W2087897706 hasConceptScore W2087897706C151730666 @default.
• W2087897706 hasConceptScore W2087897706C197934379 @default.
• W2087897706 hasConceptScore W2087897706C2778980435 @default.
• W2087897706 hasConceptScore W2087897706C2779489039 @default.
• W2087897706 hasConceptScore W2087897706C2779802037 @default.
• W2087897706 hasConceptScore W2087897706C2911091166 @default.
• W2087897706 hasConceptScore W2087897706C2994496256 @default.
• W2087897706 hasConceptScore W2087897706C501593827 @default.
• W2087897706 hasConceptScore W2087897706C523546767 @default.
• W2087897706 hasConceptScore W2087897706C54355233 @default.
• W2087897706 hasConceptScore W2087897706C61716771 @default.
• W2087897706 hasConceptScore W2087897706C71924100 @default.
• W2087897706 hasConceptScore W2087897706C86803240 @default.
• W2087897706 hasConceptScore W2087897706C89423630 @default.
• W2087897706 hasConceptScore W2087897706C90924648 @default.
• W2087897706 hasIssue "17" @default.
• W2087897706 hasLocation W20878977061 @default.
• W2087897706 hasLocation W20878977062 @default.

• next